Skip to main content
Erschienen in: International Journal of Clinical Oncology 6/2018

05.06.2018 | Original Article

Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer

verfasst von: Yasushi Ishida, Miho Maeda, Souichi Adachi, Hiroko Inada, Hiroshi Kawaguchi, Hiroki Hori, Atsushi Ogawa, Kazuko Kudo, Chikako Kiyotani, Hiroyuki Shichino, Takeshi Rikiishi, Ryoji Kobayashi, Maho Sato, Jun Okamura, Hiroaki Goto, Atsushi Manabe, Shinji Yoshinaga, Dongmei Qiu, Junichiro Fujimoto, Tatsuo Kuroda

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Backgrounds

Multidisciplinary therapy has increased the risk of subsequent late effects, but detailed analyses on secondary cancers in childhood cancer survivors (CCSs) are limited in Asian countries.

Methods

This was a retrospective cohort study comprising 10,069 CCSs who were diagnosed between 1980 and 2009 across 15 Japanese hospitals. We conducted secondary analyses to estimate the incidence of secondary cancer according to each primary malignancy and to elucidate the association between primary and secondary cancers. We also explored the risk factors for the development of secondary cancer in each independent primary malignancy.

Results

The cumulative incidence of secondary cancer at 20 years varied among primary cancers: hematological malignancy, 3.1% (95% CI 2.2–4.3); retinoblastoma, 6.6% (95% CI 1.5–16.8); pediatric solid tumor, 2.5% (95% CI 1.3–4.2); brain tumors, 5.2% (95% CI 1.7–11.8) bone/soft tissue sarcoma, 5.2% (95% CI 2.3–10.1); and others, 3.3% (95% CI 1.6–6.0) (p = 0.015). The cumulative incidence of secondary cancers is highest in those with osteosarcoma (13.1%) followed by those with hepatoblastoma (8.4%) and retinoblastoma (6.6%). Close association between the primary and secondary cancer diagnoses was found. The risk factors for secondary cancer development depended on the primary cancer, but autologous/allogeneic stem cell transplantation was a relatively common risk factor.

Conclusion

The cumulative incidence of secondary cancer varied among primary cancers. The primary cancer was closely associated with the secondary cancer but stem cell transplantation was a common risk factor for secondary cancers among CCSs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572–1582CrossRef Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572–1582CrossRef
2.
Zurück zum Zitat Hudson MM, Mulrooney DA, Bowers DC et al (2009) High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol 27(14):2405–2414CrossRef Hudson MM, Mulrooney DA, Bowers DC et al (2009) High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol 27(14):2405–2414CrossRef
3.
Zurück zum Zitat Robison LL, Hudson MM (2014) Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 14(1):61–70CrossRef Robison LL, Hudson MM (2014) Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 14(1):61–70CrossRef
4.
Zurück zum Zitat Armstrong GT, Liu Q, Yasui Y et al (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27(14):2328–2338CrossRef Armstrong GT, Liu Q, Yasui Y et al (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27(14):2328–2338CrossRef
5.
Zurück zum Zitat Reulen RC, Winter DL, Frobisher C et al (2010) Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304(2):172–179CrossRef Reulen RC, Winter DL, Frobisher C et al (2010) Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304(2):172–179CrossRef
6.
Zurück zum Zitat Meadows AT, Friedman DL, Neglia JP et al (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27(14):2356–2362CrossRef Meadows AT, Friedman DL, Neglia JP et al (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27(14):2356–2362CrossRef
7.
Zurück zum Zitat Friedman DL, Whitton J, Leisenring W et al (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102(14):1083–1095CrossRef Friedman DL, Whitton J, Leisenring W et al (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102(14):1083–1095CrossRef
8.
Zurück zum Zitat Reulen RC, Frobisher C, Winter DL et al (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305(22):2311–2319CrossRef Reulen RC, Frobisher C, Winter DL et al (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305(22):2311–2319CrossRef
9.
Zurück zum Zitat Ishida Y, Maeda M, Urayama KY et al (2014) Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children’s Cancer Study Group protocols: a retrospective cohort study. Br J Haematol 164(1):101–112CrossRef Ishida Y, Maeda M, Urayama KY et al (2014) Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children’s Cancer Study Group protocols: a retrospective cohort study. Br J Haematol 164(1):101–112CrossRef
10.
Zurück zum Zitat Ishida Y, Qiu D, Maeda M et al (2016) Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan. Int J Clin Oncol 21(3):506–516CrossRef Ishida Y, Qiu D, Maeda M et al (2016) Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan. Int J Clin Oncol 21(3):506–516CrossRef
11.
Zurück zum Zitat Kleinerman RA, Tucker MA, Tarone RE et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23(10):2272–2279CrossRef Kleinerman RA, Tucker MA, Tarone RE et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23(10):2272–2279CrossRef
12.
Zurück zum Zitat Wong FL, Boice JD Jr, Abramson DH et al (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278(15):1262–1267CrossRef Wong FL, Boice JD Jr, Abramson DH et al (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278(15):1262–1267CrossRef
13.
Zurück zum Zitat Teepen JC, van Leeuwen FE, Tissing WJ et al (2017) Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER Study cohort: role of chemotherapy. J Clin Oncol 35(20):2288–2298CrossRef Teepen JC, van Leeuwen FE, Tissing WJ et al (2017) Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER Study cohort: role of chemotherapy. J Clin Oncol 35(20):2288–2298CrossRef
14.
Zurück zum Zitat Bhatia S, Sather HN, Pabustan OB et al (2002) Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99(12):4257–4264CrossRef Bhatia S, Sather HN, Pabustan OB et al (2002) Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99(12):4257–4264CrossRef
15.
Zurück zum Zitat Loning L, Zimmermann M, Reiter A et al (2000) Secondary neoplasms subsequent to Berlin–Frankfurt–Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95(9):2770–2775PubMed Loning L, Zimmermann M, Reiter A et al (2000) Secondary neoplasms subsequent to Berlin–Frankfurt–Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95(9):2770–2775PubMed
16.
Zurück zum Zitat Schmiegelow K, Al-Modhwahi I, Andersen MK et al (2009) Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood 113(24):6077–6084CrossRef Schmiegelow K, Al-Modhwahi I, Andersen MK et al (2009) Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood 113(24):6077–6084CrossRef
17.
Zurück zum Zitat Mody R, Li S, Dover DC et al (2008) Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 111(12):5515–5523CrossRef Mody R, Li S, Dover DC et al (2008) Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 111(12):5515–5523CrossRef
18.
Zurück zum Zitat Federico SM, Allewelt HB, Spunt SL et al (2015) Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma. J Pediatr Hematol Oncol 37(1):e6–e12CrossRef Federico SM, Allewelt HB, Spunt SL et al (2015) Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma. J Pediatr Hematol Oncol 37(1):e6–e12CrossRef
19.
Zurück zum Zitat Applebaum MA, Henderson TO, Lee SM et al (2015) Second malignancies in patients with neuroblastoma: the effects of risk-based therapy. Pediatr Blood Cancer 62(1):128–133CrossRef Applebaum MA, Henderson TO, Lee SM et al (2015) Second malignancies in patients with neuroblastoma: the effects of risk-based therapy. Pediatr Blood Cancer 62(1):128–133CrossRef
20.
Zurück zum Zitat Temming P, Arendt M, Viehmann A et al (2017) Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: a report from the German reference center. Pediatr Blood Cancer 64(1):71–80CrossRef Temming P, Arendt M, Viehmann A et al (2017) Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: a report from the German reference center. Pediatr Blood Cancer 64(1):71–80CrossRef
21.
Zurück zum Zitat Applebaum MA, Vaksman Z, Lee SM et al (2017) Neuroblastoma survivors are at increased risk for second malignancies: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer 72:177–185CrossRef Applebaum MA, Vaksman Z, Lee SM et al (2017) Neuroblastoma survivors are at increased risk for second malignancies: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer 72:177–185CrossRef
22.
Zurück zum Zitat Martin A, Schneiderman J, Helenowski IB et al (2014) Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma. Pediatr Blood Cancer 61(8):1350–1356CrossRef Martin A, Schneiderman J, Helenowski IB et al (2014) Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma. Pediatr Blood Cancer 61(8):1350–1356CrossRef
23.
Zurück zum Zitat Danner-Koptik KE, Majhail NS, Brazauskas R et al (2013) Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant 48(3):363–368CrossRef Danner-Koptik KE, Majhail NS, Brazauskas R et al (2013) Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant 48(3):363–368CrossRef
24.
Zurück zum Zitat Henderson TO, Rajaraman P, Stovall M et al (2012) Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys 84(1):224–230CrossRef Henderson TO, Rajaraman P, Stovall M et al (2012) Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys 84(1):224–230CrossRef
Metadaten
Titel
Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer
verfasst von
Yasushi Ishida
Miho Maeda
Souichi Adachi
Hiroko Inada
Hiroshi Kawaguchi
Hiroki Hori
Atsushi Ogawa
Kazuko Kudo
Chikako Kiyotani
Hiroyuki Shichino
Takeshi Rikiishi
Ryoji Kobayashi
Maho Sato
Jun Okamura
Hiroaki Goto
Atsushi Manabe
Shinji Yoshinaga
Dongmei Qiu
Junichiro Fujimoto
Tatsuo Kuroda
Publikationsdatum
05.06.2018
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2018
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-018-1303-6

Weitere Artikel der Ausgabe 6/2018

International Journal of Clinical Oncology 6/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.